Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases

Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases

US Patent 9617226 · Granted Apr 11, 2017

Estimated economic value: $236,573,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Organic reactions carried out in aqueous solution in the presence of a hydroxyal2022
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Inhibitor compounds of phosphodiesterase type 10A2019
Fused (hetero)cyclic compounds as S1P modulators2019
Quinoline compounds suitable for treating disorders that respond to the modulati2018
Tricyclic quinoline and quinoxaline derivatives2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Tricyclic quinoline and quinoxaline derivatives2018
Inhibitor compounds of phosphodiesterase type 10A2018